[Form 4] GUIDEWIRE SOFTWARE, INC. Insider Trading Activity
Rhea-AI Filing Summary
Guidewire Software insider sale by CEO and director Michael G. Rosenbaum. The filing discloses an automatic sale of 1,400 shares of Guidewire common stock on 08/25/2025 at a reported price of $214.70 per share under a 10b5-1 trading plan adopted October 15, 2024. After the sale, the reporting person beneficially owned 224,668 shares. The form is signed by an attorney-in-fact on behalf of Mr. Rosenbaum and indicates the sale was executed pursuant to the written trading plan to satisfy Rule 10b5-1 affirmative defense conditions.
Positive
- Transaction executed under a 10b5-1 trading plan, which provides an affirmative defense and demonstrates procedural compliance
- Filing discloses specific post-transaction beneficial ownership (224,668 shares), giving transparency about insider holdings
Negative
- Insider sale by the Chief Executive Officer and Director may be interpreted by some investors as a reduction in insider exposure
- Sale reduces holdings by 1,400 shares, which could attract attention despite being reported as pre-planned
Insights
TL;DR: Routine, pre-planned sale by the CEO under a 10b5-1 plan; limited immediate signal about company fundamentals.
This Form 4 shows a single automatic disposition of 1,400 shares at $214.70 under a 10b5-1 plan adopted October 15, 2024, leaving the reporting person with 224,668 shares. Because the sale is identified as executed under a pre-established plan, it reduces the informational weight of the transaction as an insider "timing" signal. The transaction size relative to total holdings appears modest in absolute terms based on the remaining beneficial ownership reported. The filing is procedural and complies with Section 16 reporting requirements.
TL;DR: Governance procedure followed: sale executed via attorney-in-fact under an established 10b5-1 plan.
The document documents compliance with insider trading policies by disclosing a sale under a Rule 10b5-1 trading plan and includes an attorney-in-fact signature. This is standard governance practice for insiders seeking to transact while managing regulatory risk. The filing provides clear disclosure of relationship to the issuer (Director and Chief Executive Officer) and the mechanics of the reported sale.